Hyphens Pharma International (SGX:1J5) Long-Term Capital Lease Obligation : S$0.0 Mil (As of Jun. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Hyphens Pharma International Long-Term Capital Lease Obligation?

Hyphens Pharma International's Long-Term Capital Lease Obligation for the quarter that ended in Jun. 2023 was S$0.0 Mil.

Hyphens Pharma International's quarterly Long-Term Capital Lease Obligation declined from Jun. 2022 (S$0.5 Mil) to Dec. 2022 (S$0.1 Mil) and declined from Dec. 2022 (S$0.1 Mil) to Jun. 2023 (S$0.0 Mil).

Hyphens Pharma International's annual Long-Term Capital Lease Obligation declined from Dec. 2020 (S$1.7 Mil) to Dec. 2021 (S$0.9 Mil) and declined from Dec. 2021 (S$0.9 Mil) to Dec. 2022 (S$0.1 Mil).

Hyphens Pharma International Long-Term Capital Lease Obligation Historical Data

The historical data trend for Hyphens Pharma International's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hyphens Pharma International Long-Term Capital Lease Obligation Chart

Hyphens Pharma International Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

2.44

1.73

0.88

0.10

Hyphens Pharma International Semi-Annual Data
	Dec15	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial										1.27	0.88	0.53	0.10	0.05

Hyphens Pharma International (SGX:1J5) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Hyphens Pharma International Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Hyphens Pharma International's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Hyphens Pharma International (SGX:1J5) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Hyphens Pharma International Ltd (SGX:1J5) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

16 Tai Seng Street, Level 4, Singapore, SGP, 534138

Website

https://www.hyphensgroup.com

Hyphens Pharma International Ltd is a pharmaceutical company. Its segments include Specialty Pharma Principals segment; Proprietary Brands segment and Medical Hypermart and Digital segment. Specialty pharma principals segment engages in the business of selling and marketing specialty pharmaceutical products. Proprietary Brands segment develops, markets and sells own proprietary range of dermatological products and health supplement products through Hyphens and Ocean Health Singapore. Medical Hypermart and Digital is engaged in the wholesale of pharmaceuticals and medical supplies in Singapore through Pan-Malayan.

Hyphens Pharma International (SGX:1J5) Headlines

No Headlines